CBD classed as pharmaceutical product: Taiwan regulatory report

In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes including the extraction, and the addition of CBD to cosmetic products, is prohibited.

...
Free Sample

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ CBD classed as pharmaceutical product: Taiwan regulatory report ”

This file is not available, please fill the form to request your sample page:

[honeypot jonipor-540 move-inline-css:true]




Buy report request information:

“ CBD classed as pharmaceutical product: Taiwan regulatory report ”

[honeypot jonipor-541 move-inline-css:true]




Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.

FREE TRIAL